Read a recap of this event
Industrial policy is an important lever to spur investment, bolster the economy, and protect against predictable and unforeseen shocks. Recently exposed supply chain vulnerabilities for commonly-used pharmaceuticals presents a challenge that government intervention is well-suited to address: to limit pharmaceutical shortages and ensure that sterile injectables are both available and safe.
On June 21, The Hamilton Project hosted a webcast featuring a fireside discussion between Zeke Emanuel (University of Pennsylvania) and Mark McClellan (Duke University), moderated by Hamilton Project director Wendy Edelberg.
Afterward, Edelberg moderated a discussion between Brian McCormick (Teva Pharmaceuticals), and Marta Wosińska (Brookings).
The event coincided with the release of a new Hamilton Project proposal on related topics. For updates on the event, viewers followed @HamiltonProj on Twitter and joined the conversation using #HealthPolicy to ask questions or emailed [email protected].
10:30 a.m. | Fireside chat
Ezekiel Emanuel, Levy University Professor, and Co-Director of the Healthcare Transformation Institute, University of Pennsylvania
Mark McClellan, Robert J. Margolis Professor of Business, Medicine, and Policy, Founding Director, Duke-Margolis Center for Health Policy, Duke University
Moderator: Wendy Edelberg, Director, The Hamilton Project, Senior Fellow, Economic Studies, The Brookings Institution
11:10 a.m. | Ensuring reliable access to quality and affordable medicines
Marta Wosińska, Visiting Fellow, USC-Brookings Schaeffer Initiative for Health Policy, The Brookings Institution
Brian McCormick, Vice President, Chief Regulatory Counsel and Head of Global Regulatory Policy, Teva Pharmaceuticals
Moderator: Wendy Edelberg, Director, The Hamilton Project, Senior Fellow, Economic Studies, The Brookings Institution
